NM6603

NM6603 · NucMito Pharmaceuticals Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NM6603, covering 2025-06-12 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors [Phase 1]